In the summer of 2014, the Ice Bucket Challenge brought worldwide awareness and more than $200 million in donations to the ...

BrainStorm gets US FDA nod to begin phase 3b trial of NurOwn to treat amyotrophic lateral sclerosis: New York Wednesday, May 21, 2025, 18:00 Hrs [IST] BrainStorm Cell Therapeutics ...

At Tuesday’s meeting, the Kingsport Board of Mayor and Aldermen presented a proclamation declaring May as Amyotrophic Lateral Sclerosis (ALS) Awareness Month in the ...

Using the gene scissors CRISPR and stem cells, researchers at Stockholm University and the UK Dementia Research Institute (UK ...

Health and Human Services Secretary Robert F. Kennedy Jr. defended his proposed budget for next year on Tuesday amid ...

Peptidomimetics are synthetic analogs that retain the essential structure and function of peptides but with chemical ...

MaaT033, an experimental oral therapy that uses bacteria to restore balance in the gut, may slow ALS progression, a study ...

Understand how CT metrics match FVC in predicting ALS survival, offering a spirometry alternative for patients with bulbar ...

The US Food and Drug Administration (FDA) has granted clearance to BrainStorm Cell Therapeutics to commence a Phase IIIb ...

In a story of resilience and hope, the Weber family stands as a reminder of the impact of familial bonds in the face of ...

Patients given Neuronata-R who progressed more slowly saw significant gains in CAFS, slower declines in ALSFRS-R scores, and ...